CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NBS's Net Income Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Net Income results by quarter and year



Select the Comparisons : Select the Ratio:                        
NBS Net Income (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - -6.09 -33.23 -11.69
III Quarter September - -7.29 -11.39 -17.18
II Quarter June - -7.88 -17.16 -12.77
I Quarter March -9.79 -12.05 -19.23 -13.83
FY   -9.79 -33.31 -81.01 -55.47

Financial Statements
Caladrius Biosciences,'s first quarter 2017 Net Income $ -9.79 millions NBS's Income Statement
Caladrius Biosciences,'s first quarter 2016 Net Income $ -12.05 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Net Income ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



NBS Net Income Growth Comment
Caladrius Biosciences, Inc. in the first quarter recorded net loss of $ -9.79 millions.

According to the results reported in the first quarter, Caladrius Biosciences, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Caladrius Biosciences, Inc.' s Net Income no change of % ranks overall at the positon no. 0 in the first quarter.



Net Income Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
S&P 500 #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NBS's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NBS's Competitors
Net Income Growth for Caladrius Biosciences,'s Suppliers
Net Income Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2017
Resmed Inc -0.72 %$ -0.718 millions
Regenicin, Inc. -1.10 %$ -1.099 millions
Akorn Inc -2.05 %$ -2.051 millions
Glaukos Corp -2.12 %$ -2.118 millions
Universal Health Services Inc -2.41 %$ -2.407 millions
Hca Healthcare, Inc. -4.19 %$ -4.192 millions
National Healthcare Corp -7.78 %$ -7.782 millions
Bruker Corp -8.05 %$ -8.051 millions
Synergy Chc Corp. -8.96 %$ -8.960 millions
Halyard Health, Inc. -9.86 %$ -9.859 millions
Cryolife Inc -12.51 %$ -12.515 millions
Ani Pharmaceuticals Inc -14.41 %$ -14.413 millions
Pharmerica Corp -14.63 %$ -14.634 millions
Abaxis Inc -14.80 %$ -14.795 millions
Mednax, Inc. -19.30 %$ -19.300 millions
Anika Therapeutics, Inc. -20.33 %$ -20.334 millions
Prestige Brands Holdings, Inc. -20.42 %$ -20.422 millions
Owens & Minor Inc -22.17 %$ -22.167 millions
Biogen Inc. -22.87 %$ -22.875 millions
Ligand Pharmaceuticals Inc -23.14 %$ -23.139 millions
United Therapeutics Corp -24.16 %$ -24.161 millions
Gilead Sciences Inc -24.33 %$ -24.334 millions
Civitas Solutions, Inc. -25.10 %$ -25.099 millions
Bio-techne Corp -29.39 %$ -29.388 millions
Quintiles Ims Holdings, Inc. -30.29 %$ -30.292 millions
Steris Plc -35.61 %$ -35.612 millions
Select Medical Holdings Corp -37.07 %$ -37.071 millions
Surmodics Inc -38.67 %$ -38.667 millions
Tenax Therapeutics, Inc. -38.91 %$ -38.907 millions
Integra Lifesciences Holdings Corp -45.11 %$ -45.106 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com